Back

Global Learning Collaborative

  • Liver Cirrhosis, Biliary

Primary Biliary Cholangitis: Shining Light on an “Invisible” Female Health Burden

This WHAV 2025 session examines primary biliary cholangitis (PBC), a chronic autoimmune liver disease that predominantly affects women and often goes unrecognized. Tailored for clinicians who play a key role in identifying symptoms and initiating referrals, the session outlines diagnostic criteria including AMA positivity and elevated ALP and clarifies when specialist evaluation is warranted. Treatment strategies cover UDCA and newer agents like elafibranor and seladelpar for nonresponders. The discussion also addresses symptom burden, extrahepatic manifestations, and reproductive-stage considerations, including pregnancy.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AAPA Category 1 Credit™Up to 1 creditAMA PRA Category 1 Credit™Up to 1 creditNursingUp to 1 creditPharmacyUp to 1 credit

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Paid · fee on provider site

See fees on provaeducation.com

Listed by the provider

  • Enduring / On-demand
  • Credit · Up to 1 credit
  • Paid · fee on provider site
  • Commercial Support
  • Released
    Oct 22, 2025
  • Last day to claim credit
    Oct 23, 2026 10 days left